VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $84,446,000 | +38.9% | 3,633,591 | -4.8% | 0.11% | +31.0% |
| Q1 2018 | $60,778,000 | -8.8% | 3,817,718 | +19.1% | 0.08% | -7.7% |
| Q4 2017 | $66,608,000 | +54.4% | 3,205,372 | +6.5% | 0.09% | +37.9% |
| Q3 2017 | $43,144,000 | +24.6% | 3,010,727 | +50.4% | 0.07% | +15.8% |
| Q2 2017 | $34,628,000 | +149.7% | 2,001,571 | +59.2% | 0.06% | +137.5% |
| Q1 2017 | $13,866,000 | -86.5% | 1,257,031 | -82.2% | 0.02% | -86.2% |
| Q4 2016 | $102,525,000 | -56.5% | 7,060,960 | -26.4% | 0.17% | -58.1% |
| Q3 2016 | $235,668,000 | +52.4% | 9,599,593 | +25.0% | 0.42% | +45.6% |
| Q2 2016 | $154,651,000 | -10.9% | 7,678,791 | +16.4% | 0.28% | -8.4% |
| Q1 2016 | $173,564,000 | -71.7% | 6,599,391 | +9.3% | 0.31% | -65.9% |
| Q4 2015 | $613,507,000 | +97.0% | 6,035,566 | +245.7% | 0.91% | +98.9% |
| Q3 2015 | $311,461,000 | -24.7% | 1,746,017 | -6.2% | 0.46% | -25.5% |
| Q2 2015 | $413,597,000 | -33.7% | 1,861,812 | -40.7% | 0.62% | -35.6% |
| Q1 2015 | $623,493,000 | +144.0% | 3,139,165 | +75.8% | 0.96% | +191.5% |
| Q4 2014 | $255,508,000 | +52.3% | 1,785,392 | +39.6% | 0.33% | +51.2% |
| Q3 2014 | $167,779,000 | -29.5% | 1,278,818 | -32.3% | 0.22% | -33.0% |
| Q2 2014 | $238,082,000 | -21.3% | 1,887,688 | -17.7% | 0.32% | -25.0% |
| Q1 2014 | $302,514,000 | +51.3% | 2,294,915 | +34.7% | 0.43% | +58.2% |
| Q4 2013 | $199,976,000 | +35.1% | 1,703,466 | +20.0% | 0.27% | +15.7% |
| Q3 2013 | $148,045,000 | +6.7% | 1,419,081 | -12.0% | 0.24% | -9.6% |
| Q2 2013 | $138,784,000 | – | 1,612,040 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |